9 June 2018 in Breast Cancer Research and Treatment
EMEdna Ayerim Mandujano-Tinoco
Edna Ayerim Mandujano-Tinoco
1 May 2017 in Archives of Medical Research
CGCarolina Gonzalez-Torres
JGJavier Gaytan-Cervantes
EMEdna Ayerim Mandujano-Tinoco
Edna Ayerim Mandujano-Tinoco
GCGisela Ceballos-Cancino
+5
1 December 2019 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
EMEdna Ayerim Mandujano-Tinoco
Edna Ayerim Mandujano-Tinoco
+4
29 March 2016 in Scientific Reports
Oxygen or nutrient deprivation of early stage tumoral spheroids can be used to reliably mimic the initial growth of primary and metastatic cancer cells. However, cancer cell growth during the initial stages has not been fully explored using a genome-wide approach. Thus, in the present study, we investigated the transcriptome of breast cancer cells during the initial stages of tumoral growth using RNAseq in a model of Multicellular Tumor Spheroids (MTS). Network analyses showed that a metastatic signature was enriched as several adhesion molecules were deregulated, including EPCAM, E-cadherin, integrins and syndecans, which were further supported by an increase in cell migration. Interestingly, we also found that the cancer cells at this stage of growth exhibited a paradoxical hyperactivation of oxidative mitochondrial metabolism. In addition, we found a large number of regulated (long non coding RNA) lncRNAs, several of which were co-regulated with neighboring genes. The regulatory role of some of these lncRNAs on mRNA expression was demonstrated with gain of function assays. This is the first report of an early-stage MTS transcriptome, which not only reveals a complex expression landscape, but points toward an important contribution of long non-coding RNAs in the final phenotype of three-dimensional cellular models.
25 July 2020 in Carcinogenesis
EMEdna Ayerim Mandujano-Tinoco
Edna Ayerim Mandujano-Tinoco
+2
Multicellular tumor spheroids (MCTSs) constitute a three-dimensional culture system that recapitulates the in vivo tumor microenvironment. Tumor cells cultured as MCTSs present antineoplastic resistance due to the effect of microenvironmental signals acting upon them. In this work, we evaluated the biological function of a new microenvironment-regulated long non-coding RNA, lncMat2B, in breast cancer. In MCTSs, the expression of lncMat2B presented an increase and a zonal heterogeneity, as it was expressed principally in quiescent cells of hypoxic regions of the MCTSs. As expected, functional assays supported the role of severe hypoxia in the regulation of lncMat2B. Moreover, gain- and loss-of-function assays using a transcriptional silencing CRISPR/Cas9 system and gBlock revealed that lncMAT2B regulates the tumor-initiating phenotype. Interestingly, lncMat2B is overexpressed in a cisplatin-resistant MCF-7 cell line, and its ectopic expression in wild type MCF-7 cells increased survival to cisplatin exposure by reducing DNA damage and reactive oxygen species accumulation. lncMAT2B is a possible link between severe hypoxia, tumor-initiating phenotype and drug resistance in breast cancer cells.
1 October 2017 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
EMEdna Ayerim Mandujano-Tinoco
Edna Ayerim Mandujano-Tinoco
FLFloria Lizarraga-Sanchez
+4